A Month After Brazil's Vote, the Safety Review Still Has No Verdict

SAO PAULO — Brazil's federal augmentation vote closed a month ago, but the technical question it could not answer remains open, contested, and unhurried. Somaform Augmetics' neural-interface line is still under the safety review that began before the ballot, and regulators have neither cleared it nor pulled it. "A vote decides what a society permits," said Dr. Naomi Eze, tracking the review for this desk. "It does not decide what is safe. Those are different clocks." Roughly five percent of humans now carry some augmentation, and the interface at issue sits at the contested edge — deep enough to promise real function, deep enough to worry the clinicians reviewing it. Julian Morrow, Somaform's founder, has urged patience over recall, calling the scrutiny "the price of doing this properly." His critics call the same delay a hazard left running. The review continues into autumn with no timeline, a reminder that the ballot settled the politics and left the medicine exactly where it stood.